









市場行情
/
股票
/
nasdaq-hae
/

Haemonetics Corp

HAE

80.240USD

+0.230+0.29%

收盤 12/26, 16:00（美東）報價延遲15分鐘

3.75B總市值

23.37本益比TTM



Haemonetics Corp

80.240

+0.230+0.29%

概覽公司財務分析

概覽

公司

財務

分析

關於 Haemonetics Corp 公司

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Haemonetics Corp簡介



公司代碼HAE

公司名稱Haemonetics Corp

上市日期Oct 17, 1979

CEOSimon (Christopher A)

員工數量3023

證券類型Ordinary Share

年結日Oct 17

公司地址125 Summer Street

城市BOSTON

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編02110

電話17818487100

網址https://www.haemonetics.com

公司代碼HAE

上市日期Oct 17, 1979

CEOSimon (Christopher A)

Haemonetics Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.01K

-0.84%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

24.76K

+5.99%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

Mr. Michael J. Coyle

Independent Director

15.39K

+21.20%

Ms. Diane M. Bryant

Independent Director

7.13K

+60.75%

Mr. Roy Galvin

Executive Vice President, Chief Commercial Officer

3.24K

-4.28%

Mr. Frank W. Chan

Chief Operating Officer, Executive Vice President

名稱

名稱/職務

職務

持股

持股變動

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.01K

-0.84%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

24.76K

+5.99%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

收入明細

單位: USD更新時間: 10月6日週一

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

United States

242.40M

75.42%

Europe

40.88M

12.72%

Asia

21.65M

6.74%

Japan

13.65M

4.25%

other

2.81M

0.87%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.33%

The Vanguard Group, Inc.

10.30%

Neuberger Berman, LLC

7.84%

AQR Capital Management, LLC

4.55%

State Street Investment Management (US)

3.85%

其他

62.13%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.33%

The Vanguard Group, Inc.

10.30%

Neuberger Berman, LLC

7.84%

AQR Capital Management, LLC

4.55%

State Street Investment Management (US)

3.85%

其他

62.13%

股東類型

持股股東

佔比

Investment Advisor

50.18%

Investment Advisor/Hedge Fund

45.79%

Hedge Fund

9.57%

Research Firm

4.36%

Bank and Trust

1.39%

Individual Investor

1.23%

Sovereign Wealth Fund

1.13%

Pension Fund

1.03%

Family Office

0.11%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

697

54.60M

116.65%

-5.18M

2025Q2

700

57.31M

118.95%

-4.19M

2025Q1

723

57.94M

120.44%

-3.07M

2024Q4

701

58.48M

116.40%

-1.44M

2024Q3

689

57.60M

112.60%

-1.51M

2024Q2

668

57.60M

113.31%

+3.07M

2024Q1

655

52.49M

103.35%

-1.26M

2023Q4

647

51.85M

102.19%

-3.31M

2023Q3

657

52.00M

102.54%

-4.11M

2023Q2

656

51.75M

102.38%

-4.68M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.57M

11.56%

-96.61K

-1.71%

Jun 30, 2025

The Vanguard Group, Inc.

4.94M

10.26%

-145.60K

-2.86%

Jun 30, 2025

Neuberger Berman, LLC

4.28M

8.88%

-70.91K

-1.63%

Jun 30, 2025

State Street Investment Management (US)

1.88M

3.91%

-34.03K

-1.77%

Jun 30, 2025

River Road Asset Management, LLC

1.66M

3.44%

+260.62K

+18.68%

Jun 30, 2025

UBS Financial Services, Inc.

869.79K

1.81%

+453.69K

+109.04%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.24M

2.58%

+23.26K

+1.90%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.07M

2.23%

+9.05K

+0.85%

Jun 30, 2025

Allspring Global Investments, LLC

949.48K

1.97%

-16.68K

-1.73%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Neuberger Berman Small-Mid Cap ETF

2.34%

State Street SPDR S&P Health Care Equipment ETF

1.66%

Harbor Human Capital Factor US Small Cap ETF

1.51%

Lattice Hartford Multifactor Small Cap ETF

0.54%

Inspire Small/Mid Cap ESG ETF

0.34%

WisdomTree US SmallCap Quality Growth Fund

0.3%

Principal U.S. Small-Cap ETF

0.28%

VictoryShares US Small Mid Cap Value Momentum ETF

0.26%

Royce Quant Small-Cap Quality Value ETF

0.24%

Amplify Etho Climate Leadership U.S. ETF

0.22%

Neuberger Berman Small-Mid Cap ETF

佔比2.34%

State Street SPDR S&P Health Care Equipment ETF

佔比1.66%

Harbor Human Capital Factor US Small Cap ETF

佔比1.51%

Lattice Hartford Multifactor Small Cap ETF

佔比0.54%

Inspire Small/Mid Cap ESG ETF

佔比0.34%

WisdomTree US SmallCap Quality Growth Fund

佔比0.3%

Principal U.S. Small-Cap ETF

佔比0.28%

VictoryShares US Small Mid Cap Value Momentum ETF

佔比0.26%

Royce Quant Small-Cap Quality Value ETF

佔比0.24%

Amplify Etho Climate Leadership U.S. ETF

佔比0.22%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Haemonetics Corp的前五大股東是誰？



Haemonetics Corp的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：5.57M
佔總股份比例：11.56%。
The Vanguard Group, Inc.
持有股份：4.94M
佔總股份比例：10.26%。
Neuberger Berman, LLC
持有股份：4.28M
佔總股份比例：8.88%。
State Street Investment Management (US)
持有股份：1.88M
佔總股份比例：3.91%。
River Road Asset Management, LLC
持有股份：1.66M
佔總股份比例：3.44%。